A comparative study on intraoperative mitomycin-c augmented external dacryocystorhinostomy with conventional dacryocystorhinostomy

Bharoti Sarmah Puzari; Pramod Kumar H. N.

doi:10.18203/2320-6012.ijrms20162887

Authors

Bharoti Sarmah Puzari Department of Ophthalmology, Assam Medical College and Hospital, Dibrugarh, Assam
Pramod Kumar H. N. Department of Ophthalmology, Assam Medical College and Hospital, Dibrugarh, Assam

DOI:

https://doi.org/10.18203/2320-6012.ijrms20162887

Keywords:

Dacryocystorhinostomy, Nasolacrimal duct, Mitomycin-C, Antiproliferative

Abstract

Background: Dacryocystorhinostomy (DCR) is a commonly done surgery performed for management of epiphora due to nasolacrimal duct obstruction. Goal of the procedure is to bypass the obstructed nasolacrimal duct allowing tear drainage into the nasal cavity directly from lacrimal sac by creating an anastomosis between the lacrimal sac and the nasal mucosa via a bony ostium. Common cause of DCR failure are attributed as an end effect of fibrous tissue growth, scarring and granulation tissue formation which obstructs the new drainage channel. Mitomycin c is an antiproliferative agent and may enhance the result of DCR by inhibiting fibrous tissue proliferation. Here we aim to evaluate the results of intraoperative mitomycin C application in dacryocystorhinostomy surgery compared with the result of conventional DCR.
Methods: A prospective randomized comparative study of one year duration was done in the Department of Ophthalmology, Assam Medical College and Hospital, Dibrugarh, Assam, India. A total of 60 patients of acquired nasolacrimal duct obstruction were enrolled and divided randomly into two groups, 30 nos of patients in each group. One group had undergone conventional external DCR operation and other group was treated with DCR surgery with intraoperative mitomycin C application at the anastomotic flap and osteotomy site. Patients were reviewed after 1week, 1month, 3month and 6months postoperatively. The results of DCR surgeries were evaluated by observation of different parameters such as height of tear meniscus and patency of the nasolacrimal passage.
Results: In our study we have observed that majority of cases were in 21-30 years age group with female preponderance (male vs female; 35% vs 75%). Chronic dacryocystitis was seen in majority of cases (70%) followed by mucocele (26.67%) and lacrimal fistula (3.33%). Major difficulties encountered during surgery and postoperatively were almost identical in both the groups. There was no case of abnormal mucosal bleeding, mucosal necrosis, delayed wound healing in patients which underwent DCR with mitomycin C use. Post-operative care and follow up were done identically in both the groups. It was seen that a total success rate of 80% was achieved in conventional group where as 96.67% success was achieved in MMC group at the end of 6 months. In case of scar prone conditions like lacrimal fistula mitomycin C use has shown to be efficacious in maintaining patency of the system after surgery.
Conclusions: Distinctly higher success rate have been achieved in patients undergoing DCR with intra-operative MMC as compared to patients undergoing conventional DCR. Use of intraoperative mitomycin C can be considered safe and simple but very effective modification of conventional external DCR.

Metrics

Metrics Loading ...

References

Tarbet KJ, Custer PL. External dacryocystorhinostomy surgical success, patient satisfaction and economic costs. Ophthalmology. 1995;102:1065-70.

Welham RA, Henderson PH. Results of dacryocystorhinostomy. Analysis of causes for failures. Trans Ophthalmol Soc UK. 1973;93:601-9.

Mohd JA, Santosh GH, Milind NN. Dacryocystorhinostomy: tips and tricks, Oman J Ophthalmol. 2012;5(3):191-5.

Nerad JA. Lacrimal surgery. Section VI. In: Principle and practice of ophthalmic plastic and reconstructive surgery, Stephen Bosniak (ed). 1st edition. Philadelphia: WB Saunders Company. 1996;729-834.

Pico G. A modified technique of external dacryocystorhinostomy. Am J Ophtha. 1971;72:679-90.

Shin S, Thurairaja. External dacryorhinocystostomy-an end of an era? British J Ophthalmol. 1997;81:716-7.

Jones LJ. An anatomical approach to problems of the eyelids and lacrimal apparatus. Archieves Ophthalmology. 1961;66:137-49.

Mc LCJ, Cree IA, Rose GE. Rhinostomies: an open and shunt case? British J Ophthalmol. 1999;83:1300-1.

Tarbet KJ, Custer PL. External dacryocystorhinostomy. Surgical success, patient satisfaction and economic cost. Ophthalmology. 1995;102(7):1065-70.

Ezra E, Restori M, Mannor GE, Rose GE. Ultrasonic assessment of rhinostomy size following external dacryorhinostomy. British J Ophthalmol. 1998:82:786-9.

Iqbal A, Khan O. External dacryocystorhinostomy with and without intraoperative mitomycin-C application in adults. Ophthalmology. 2012;10(3):262-5.

Allen K, Berlin AJ. Dacryocystorhinostomy failure association with nasolacrimal silicone intubation. Ophthal Surg. 1989;20:486-9.

Rosen N, Sharir M, Moverman DC. Dacryocystorhinostomy with silicone tubes: evaluation of 253 cases. Ophthalmic Surg. 1989:20:115-9.

Baldeshi L, Nardi M, Hintschich CR, Koornneef L. Anterior suspended flaps: a modified approach for external dacryocystorhinostomy. British J Ophthalmol. 1998;82:790-2.

Goswami BJ, Chakravarthy D, Das K. Mitomycin c as useful adjunct in external dacryocystorhinostomy in scar-prone condition. All India Ophthalmological Society Year Book. 2002;517-9.

Kopp ED, Seregard S. Epiphora as a side effect of topical mitomycin C. Br J Ophthalmol. 2004;88:1422-4.

Liao LS , Kao SCS, Tseng JHS, Chen MS, Hou PK. Results of intraoperative mitomycin C application in dacryocystorhinostomy. Br J Ophthalmol. 2000;84:903-6.

Tsai CC, Kau HC, Kau SC, Hsu WM, Liu JH. Efficacy of probing the nasolacrimal duct with adjunctive mitomycin C for epiphora in adults. Ophthalmology. 2002;109(1):172-4.

Chaudhuri A, Choudhuri P, Ahir HD. Study of comparison between dacryocystorhinostomy surgery. National Journal Med Res. 2012;2(4);508-11.

Basil JH. Symptomatic epiphora. Br J Ophthalmol. 1959;43:415.

Iliff CE. A simplified dacryocystorhinostomy. Arch Ophthal. 1971;85:586-91.

Shigeta K, Takegoshi H, Kikuchi S. Sex and age differences in the bony nasolacrimal canal. Arch Ophthalmol. 2007;125:1677-81.

Nelson LB, Calhoun JH, Menduke H. Medical management of congenital nasolacrimal duct obstruction. Ophthalmology. 1985;92:1187-90.

Welham RAN, Wulc AE. Management of unsuccessful lacrimal surgery. British J Ophthalmol. 1987;71:152-7.

Mc PSD, Egelston D. Dacryocystorhinostomy: a review of 106 operations. Am J Ophthalmol. 1959;47:328-31.

Allen K, Berlin AJ. Dacryorhinocystostomy failure: association with nasolacrimal silicone intubation. Ophthalmic Surg. 1989;20:486-9.

Mc LDL, Shannon GM, Flanagan JC. Results of dacryocystorhinostomy: analysis of the reoperations. Ophthalmic Surg. 1980;11:427-30.

Linberg JV, Anderson RL, Bumsted RM. Study of intranasal ostium external dacryocystorhinostomy. Arch Ophthalmol. 1982;100:1758-62.

Ahmed SS, Ahmad R. Results of intraoperative mitomycin C application in dacryocystorhinostomy, JK Science. Journal Med Edu Res. 2002;4(1):27-31.

Rahman A, Channa S, Niazi JH, Memon MS. Dacryocystorhinostomy without intubation with intraoperative mitomycin C. J Coll Physicians Surg Pak. 2006;16(7):476-8.

Yildirim C, Yaylali V, Esme A, Ozen S. Long-term results of adjunctive use of mitomycin c in external dacryocystorhinostomy. Int Ophthalmol. 2007;27(1):31-5.

Seyhmus A, Ramazan G, Serdar S, Ahmet A. Use of adjunctive mitomycin C in external dacryocystorhinostomy surgery compared with surgery alone in patients with nasolacrimal duct obstruction: a prospective double masked randomized controlled trial. Current Therap Res. 2009;70(4):267-73.